Labcorp Files 8-K: Regulation FD & Exhibits
Ticker: LH · Form: 8-K · Filed: Sep 24, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Sep 24, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, regulation-fd, exhibits
Related Tickers: LH
TL;DR
Labcorp filed a routine 8-K. Nothing new to see here.
AI Summary
Labcorp Holdings Inc. filed an 8-K on September 24, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements for this form.
Why It Matters
This filing indicates Labcorp is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine filing that does not disclose new material information or significant business changes.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- 0000920148-24-000109 (filing_id) — Accession Number
- September 24, 2024 (date) — Filing Date
- 358 South Main Street, Burlington, North Carolina 27215 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits, as indicated in the filing information.
What is the exact name of the company filing this report?
The exact name of the company filing this report is LABCORP HOLDINGS INC.
On what date was this 8-K filing submitted?
This 8-K filing was submitted on September 24, 2024.
Where are the principal executive offices of Labcorp Holdings Inc. located?
The principal executive offices of Labcorp Holdings Inc. are located at 358 South Main Street, Burlington, North Carolina 27215.
Does this filing indicate any significant new financial information or events?
No, this filing primarily indicates a Regulation FD Disclosure and the submission of Financial Statements and Exhibits, without detailing specific new financial figures or material events in the provided text.
Filing Stats: 434 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2024-09-24 16:21:05
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240924.htm (8-K) — 24KB
- formpr3q24ex991earningsann.htm (EX-99.1) — 6KB
- lc2020logov2.gif (GRAPHIC) — 5KB
- 0000920148-24-000109.txt ( ) — 160KB
- lh-20240924.xsd (EX-101.SCH) — 2KB
- lh-20240924_lab.xml (EX-101.LAB) — 22KB
- lh-20240924_pre.xml (EX-101.PRE) — 12KB
- lh-20240924_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press release dated September 24, 2024 issued by Labcorp
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary September 24, 2024